UK Minister for Investment Lord Dominic Johnson has chosen Hampton Court Palace as the venue for next week’s Global Investment Summit.

The event on 27 November will focus on ‘Great British Ideas – Past, Present and Future’ and will be attended by over 200 business CEOs. The summit will explore opportunities for investing in sectors including technology, sustainability, life sciences, advanced manufacturing and creative industries.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The summit attracts big names in the FDI industry. Last week, the UK government said JP Morgan’s CEO Jamie Dimon and his counterpart at Goldman Sachs David Solomon will attend the event, which seeks to attract greater capital for UK companies and markets.

Since Brexit, the UK has struggled with political instability and faltering foreign direct investment (FDI) levels. In 2021, seven out of twelve regions across the country experienced net disinvestment, according to a parliamentary briefing published in June 2023. At the same time, London accounted for nearly half (45%) of the stock of inward FDI in the UK, while the southeast of England accounted for 17%.

Of the summit, Johnson said: “The UK is a top global investment destination, and this event will help secure billions of pounds of valuable investment that has the power to drive economic growth and create jobs.

“I’m hugely excited that our Global Investment Summit will be staged at the historic Hampton Court Palace. For centuries, this Palace was a focal point for exploration, innovation and discovery, with famous Britons from Henry VIII to William Shakespeare having lived or visited here.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Recognised with 2025 Excellence Awards for Research and Development and Marketing , Novotech converted FDA/EMA fast track designations into faster HDV trial timelines while translating complex HBV science into sponsor ready insights. Discover how this dual strength in execution and communication is reshaping liver disease clinical development.

Discover the Impact